ROCKET PHARMACEUTICALS INC's ticker is RCKT and the CUSIP is 77313F106. A total of 57 filers reported holding ROCKET PHARMACEUTICALS INC in Q1 2018. The put-call ratio across all filers is 0.29 and the average weighting 0.9%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $222,000 | +54.2% | 10,813 | +49.5% | 0.00% | – |
Q2 2023 | $144,000 | -92.0% | 7,234 | -93.1% | 0.00% | – |
Q1 2023 | $1,795,000 | +784.2% | 104,765 | +909.0% | 0.00% | – |
Q4 2022 | $203,000 | +2155.6% | 10,383 | +1848.0% | 0.00% | – |
Q3 2022 | $9,000 | -96.5% | 533 | -97.2% | 0.00% | – |
Q2 2022 | $259,000 | +547.5% | 18,829 | +643.3% | 0.00% | – |
Q1 2022 | $40,000 | -79.5% | 2,533 | -71.7% | 0.00% | – |
Q4 2021 | $195,000 | +91.2% | 8,941 | +162.3% | 0.00% | – |
Q3 2021 | $102,000 | -15.0% | 3,409 | +25.3% | 0.00% | – |
Q2 2021 | $120,000 | -92.5% | 2,720 | -92.4% | 0.00% | – |
Q1 2021 | $1,592,000 | +19800.0% | 35,886 | +26286.8% | 0.00% | – |
Q4 2020 | $8,000 | +300.0% | 136 | -9.3% | 0.00% | – |
Q1 2020 | $2,000 | -92.3% | 150 | -86.7% | 0.00% | – |
Q4 2019 | $26,000 | +62.5% | 1,124 | +77.0% | 0.00% | – |
Q3 2018 | $16,000 | -52.9% | 635 | -63.5% | 0.00% | – |
Q2 2018 | $34,000 | -24.4% | 1,741 | -27.3% | 0.00% | – |
Q1 2018 | $45,000 | – | 2,394 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
M28 Capital Management LP | 715,880 | $11,354,000 | 10.44% |
RTW INVESTMENTS, LP | 15,802,802 | $250,632,000 | 5.19% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 63,000 | $17,884,000 | 4.03% |
TANG CAPITAL MANAGEMENT LLC | 1,265,900 | $20,077,000 | 4.02% |
Prosight Management, LP | 203,268 | $3,224,000 | 2.08% |
COWEN AND COMPANY, LLC | 1,000,000 | $15,860,000 | 1.53% |
Boxer Capital, LLC | 1,466,051 | $23,252,000 | 1.20% |
Cormorant Asset Management, LP | 868,550 | $13,775,000 | 1.06% |
Amitell Capital Pte Ltd | 97,331 | $1,544,000 | 0.90% |
SECTORAL ASSET MANAGEMENT INC | 303,975 | $4,821,000 | 0.86% |